Invention Grant
US08492385B2 Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof
有权
N-α-（2,4,6-三异丙基苯基磺酰基）-3-羟基脒基 - （L） - 苯丙氨酸4-乙氧基羰基哌嗪和/或其盐的结晶修饰
- Patent Title: Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof
- Patent Title (中): N-α-（2,4,6-三异丙基苯基磺酰基）-3-羟基脒基 - （L） - 苯丙氨酸4-乙氧基羰基哌嗪和/或其盐的结晶修饰
-
Application No.: US12749140Application Date: 2010-03-29
-
Publication No.: US08492385B2Publication Date: 2013-07-23
- Inventor: Alfons Grunenberg , Jana Lenz
- Applicant: Alfons Grunenberg , Jana Lenz
- Applicant Address: DE Munich
- Assignee: Wilex AG
- Current Assignee: Wilex AG
- Current Assignee Address: DE Munich
- Agency: Saul Ewing LLP
- Agent Gianna Julian-Arnold
- Priority: DE102004057195 20041126
- Main IPC: A61K31/4965
- IPC: A61K31/4965 ; C07D295/00
Abstract:
The present invention relates to novel crystalline modifications of N-α-(2,4,6-triisopropylphenyl-sulfonyl)-3-hydroxyamidino-(L)-phenylalanine 4-ethoxy-carbonylpiperazide and/or salts thereof, which can be used as pharmaceutical agents, and to pharmaceutical compositions and pharmaceutical uses comprising these novel crystalline modifications.
Public/Granted literature
Information query
